# Grant R16GM146679 Research Foundation Of The City University Of New York > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/nih-cannabis-research-funding-city-university/ > **Published:** 2026-04-08T03:11:45-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:05:29-04:00 > **Clinical Summary:** Explore NIH cannabis research funding supporting evidence-based medicine and clinical research infrastructure at City University of New York. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic ResearchFederal Policy[Evidence-Based Medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/)Clinical Guidelines Why This Matters Federal NIH funding for [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) represents a critical shift toward [evidence-based medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/) in this field. Research grants like R16GM146679 help establish the controlled studies needed to move beyond anecdotal reports and develop standardized clinical protocols. Clinical Summary NIH grant R16GM146679 to the Research Foundation of The City University of New York indicates federal investment in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) infrastructure. While specific research objectives are not detailed in the source material, NIH R16 grants typically support research capacity building at institutions with limited research resources. This funding mechanism helps establish the laboratory and clinical capabilities necessary for rigorous cannabis studies. Dr. Caplan’s Take “Federal research funding is essential for developing the evidence base we desperately need in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Without NIH-level rigor, we’re left making clinical decisions based on incomplete data.” Clinical Perspective 🧠 Clinicians should watch for peer-reviewed publications emerging from federally-funded cannabis research programs. These studies will likely provide higher-quality evidence than industry-sponsored research and may inform future clinical guidelines and dosing protocols. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Grant%20R16GM146679%20Research%20Foundation%20Of%20The%20City%20University%20Of%20New%20York%20%40drcaplan&url=https%3A//www.highergov.com/grant/R16GM146679/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.highergov.com/grant/R16GM146679/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Grant%20R16GM146679%20Research%20Foundation%20Of%20The%20City%20University%20Of%20New%20York%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.highergov.com/grant/R16GM146679/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.highergov.com/grant/R16GM146679/](https://www.highergov.com/grant/R16GM146679/) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What topics does this cannabis news article cover?](#What_topics_does_this_cannabis_news_article_cover) - [Who is the target audience for this content?](#Who_is_the_target_audience_for_this_content) - [What does “Notable Clinical Interest” mean in this context?](#What_does_8220Notable_Clinical_Interest8221_mean_in_this_context) - [How does this relate to evidence-based medicine?](#How_does_this_relate_to_evidence-based_medicine) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to rate medical news and research on a scale, with this article receiving a #70 rating for “Notable Clinical Interest.” This indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What topics does this cannabis news article cover? Based on the tags, this article covers research findings, federal policy developments, evidence-based medicine, and clinical guidelines related to cannabis. It appears to focus on clinically relevant information for healthcare providers. #### Who is the target audience for this content? This content is primarily aimed at healthcare professionals, particularly those working in clinical settings. The emphasis on clinical relevance, evidence-based medicine, and clinical guidelines suggests it’s designed for medical practitioners who may encounter cannabis-related [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. #### What does “Notable Clinical Interest” mean in this context? “Notable Clinical Interest” indicates that the content contains emerging findings or policy developments that healthcare professionals should be aware of and monitor. While not necessarily requiring immediate action, these developments may impact future clinical practice or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. #### How does this relate to evidence-based medicine? The article is tagged with “Evidence-Based Medicine,” suggesting it presents cannabis-related information that is grounded in scientific research and clinical evidence. This approach helps healthcare providers make informed decisions based on current research rather than anecdotal information. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Cannabis research is more than a scientific pursuit—it's a pathway to better health, informed … Discover how cannabis research contributes to improved health outcomes and informed clinical practices. Learn More [“Today we can start medical research in the USA on Cannabis … This is part of the continuing …](https://cedclinic.com/starting-federally-backed-cannabis-clinical-trials-usa/) An overview of the evolving landscape of [medical cannabis research](https://cedclinic.com/cannabis-varieties-differentiation-cannabinomics/) in the USA and its significance. [Read Article](https://cedclinic.com/starting-federally-backed-cannabis-clinical-trials-usa/) Who is putting in the work for cannabis research? – YouTube Explore the key researchers and institutions driving cannabis research forward in this informative video. Watch Now ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).